Novo Holdings A/S 13D and 13G filings for Entasis Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-08-11 4:30 pm Sale |
2020-08-06 | 13G | Entasis Therapeutics Holdings Inc. ETTX |
Novo Holdings A/S | 1,173,896 4.300% |
-1,007,947 (-46.20%) |
Filing |
| 2020-06-16 1:54 pm Unchanged |
2020-06-11 | 13G | Entasis Therapeutics Holdings Inc. ETTX |
Novo Holdings A/S | 2,181,843 7.990% |
0 (Unchanged) |
Filing |